Probiotics (Lactobacillus acidophilus and Lactobacillus rhamnosus GG) in Conjunction with Celecoxib (selective COX-2 inhibitor) Modulated DMH-Induced Early Experimental Colon Carcinogenesis

References

• Montovani A: Cancer inflaming metastasis. Nature 457, 36–37, 2009.
   PubMed Web of Science ®Google Scholar
• Vaish V, Tanwar L, Kaur J, and Sanyal SN: Chemopreventive effects of non-steroidal anti-inflammatory drugs in early neoplasm of experimental colorectal cancer: An apoptosome study. J Gastrointest Canc 42, 195–203, 2011.
   PubMedGoogle Scholar
• Logan CY and Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20, 781–810, 2004.
   PubMed Web of Science ®Google Scholar
• Fodde R: The APC gene in colorectal cancer. Eur J Cancer 38, 867–871, 2002.
   PubMed Web of Science ®Google Scholar
• Kaler P, Augenlicht L, and Klampfer L: Macrophage-derived IL-1 beta stimulates Wnt signaling and growth of colon cancer cells: A crosstalk interrupted by vitamin D3. Oncogene 28, 3892–3902, 2009.
   PubMed Web of Science ®Google Scholar
• Easwaran V, Lee S, Lnge L, Guo L, Goldbeck C, et al.: β-Catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Res 63, 3145–3153, 2003.
   PubMed Web of Science ®Google Scholar
• Nakanishi Y, Ochiai A, Akimoto S, Kato H, Watanabe H, et al.: Expression of E-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: Immunohistochemical analysis of 96 lesions. Oncology 54, 158–165, 1997.
   PubMed Web of Science ®Google Scholar
• Fuchs M, Hermannstadter C, Specht K, Knyazev P, Ullrich A, et al.: Effect of tumor-associated mutant E-cadherin variants with defects in exons 8 or 9 on matrix metalloproteinase 3. J Cell Physiol 202, 805–813, 2005.
   PubMed Web of Science ®Google Scholar
• Vaish V and Sanyal SN: Role of Sulindac and Celecoxib in the regulation of angiogenesis during the early neoplasm of colon: Exploring PI3-K/PTEN/Akt pathway to the canonical Wnt/b-catenin signaling. Biomed Pharmacother 66, 354–367, 2012.
   PubMed Web of Science ®Google Scholar
• Harper KA and Tyson-Capper AJ: Complexity of COX-2 gene regulation. Biochem Soc Trans 36, 543–545, 2008.
   PubMed Web of Science ®Google Scholar
• Wang D, Dubois RN: Eicosanoids and cancer. Nat Rev Cancer 10, 181–193, 2010.
   PubMed Web of Science ®Google Scholar
• Prasad R and Kawaguchi S: A nucleus-based quality control mechanism for cytosolic proteins. Mol Biol Cell 21, 2117–2117, 2010.
   PubMed Web of Science ®Google Scholar
• Baldwin AS: Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappa-B. J Clin Invest 107, 241–246, 2001.
   PubMed Web of Science ®Google Scholar
• Zhang M, Yao Z, Dubois S, Ju W, Müller JR, et al.: Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer. Proc Natl Acad Sci USA 106, 7513–7518, 2009.
   PubMed Web of Science ®Google Scholar
• Vaish V, Tanwar L and Sanyal SN: The role of NF-κB and PPARγ in experimentally induced colorectal cancer and chemoprevention by cyclooxygenase-2 inhibitors. Tumour Biol 31, 427–436, 2010.
   PubMedGoogle Scholar
• Crawford S: Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy. Front Pharmacol 4, 68, 2013.
   PubMed Web of Science ®Google Scholar
• Wang J, Liu L, Qiu H, Zhang X, and Guo W: Ursolic acid simultaneously targets multiple signaling pathways to suppress proliferation and induce apoptosis in colon cancer cells. PloS ONE 8, 1, 2013.
   Web of Science ®Google Scholar
• Fooks LJ, Fuller R and Gibson GR: Prebiotics, probiotics and human gut microbiology. Int Dairy J 9, 53–61, 1999.
   Web of Science ®Google Scholar
• Kubota Y: Fecal intestinal flora in patients with colon adenoma and colon cancer. Nippon-Shoh. Gakkai-Zasshi 87, 771–779, 1990.
   Google Scholar
• Wollowski I, Rechkemmer G, and Pool-Zobel BL: Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr 73, 451S–455S, 2001.
   PubMed Web of Science ®Google Scholar
• Axelrad EJ, Lichtiger S, and Yajnik V: Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol 22 (20), 4794–4801, 2016.
   PubMed Web of Science ®Google Scholar
• Choi JK, Kim DW, Shin SY, Park EC, and Kang JC: Effect of ulcerative colitis on incidence of colorectal cancer: Results from the nationwide Population-Based cohort study (2003-2013). Journal of Cancer 7 (6), 681–686, 2016.
   PubMed Web of Science ®Google Scholar
• Belkaid Y and Hand T: Role of the microbiota in immunity and inflammation. Cell 157(1), 121–141, 2014.
   PubMed Web of Science ®Google Scholar
• Sharma M and Shukla G: Metabiotics: One step ahead of probiotics; an insight into mechanisms involved in anticancerous effect in colorectal cancer. Front Microbiol, 7, 1940, 2016.
   PubMed Web of Science ®Google Scholar
• Verma A and Shukla G: Probiotics Lactobacillus rhamnosus GG, Lactobacillus acidophilus suppresses DMH-induced procarcinogenic fecal enzymes and preneoplastic aberrant crypt foci in early colon carcinogenesis in sprague dawley rats. Nutr Cancer 65, 84–91, 2013a.
   PubMed Web of Science ®Google Scholar
• Verma A and Shukla G: Administration of prebiotic inulin suppresses 1,2 dimethylehydrazine dihydrochloride induced procarcinogenic biomarkers fecal enzymes and preneoplastic leision in early colon carcinogenesis in Sprague Dawley rats. J Funct Foods 5, 991–996, 2013b.
   Web of Science ®Google Scholar
• Verma A and Shukla G: Synbiotic (Lactobacillus rhamnosus + Lactobacillus acidophilus + inulin) attenuates oxidative stress and colonic damage in 1,2 dimethylhydrazine dihydrochloride-induced colon carcinogenesis in Sprague-Dawley rats: A long-term study. Eur. J. Cancer Prev 23(6), 550–559, 2014.
   PubMed Web of Science ®Google Scholar
• Food and Agriculture Organization and World Health Organization Expert Consultation. Evaluation of Health and Nutritional Properties of Powder Milk and Live Lactic Acid Bacteria. Córdoba, Argentina: Food and Agriculture Organization of the United Nations and World Health Organization, 2001.
   Google Scholar
• Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, et al.: Diet, nutrition, and avoidable Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 121, 241–246, 1994.
   PubMed Web of Science ®Google Scholar
• Sobhani I, Tap J, Roudot-Toraval F, Roperch JP, Letulle S, et al.: Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS ONE 6, e16393, 2011.
   PubMed Web of Science ®Google Scholar
• Smalley W, Ray W, Daugherty J, and Griffin MR: Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: A population based study. Arch Intern Med, 159, 161–166, 1999.
   PubMed Web of Science ®Google Scholar
• Kim B and Giardiello FM: Chemoprevention in familial adenomatous polyposis. Best Pract Res Clin Gastroenterol, 25, 607–622, 2011.
   PubMed Web of Science ®Google Scholar
• Steinbach G, Mlynch P, Phillips KSR, Wallace MH, Hawk E, et al.: The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med, 342, 1946–1952, 2000.
   PubMed Web of Science ®Google Scholar
• Solomon SD, Wittes J, Finn PV, Fowler R, Vinor J, et al.: Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: The cross trial safety analysis. Circulation 117, 2104–2113, 2008.
   PubMed Web of Science ®Google Scholar
• Manzano A and Perez-Segura P: Colorectal cancer chemoprevention: Is this the future of colorectal cancer? Sci World J, 2012, 327–341, 2012.
   Web of Science ®Google Scholar
• Pham TT, Miller MJ, Harrison DL, Lloyd AE, Crosby KM, et al.: Cardiovascular disease and non-steroidal anti-inflammatory drug prescribing in the midst of evolving guidelines. J Eval Clin Pract 19, 1026–1034, 2013.
   PubMed Web of Science ®Google Scholar
• Shukla G, Devi P, and Sehgal R: Effect of Lactobacillus casei as a probiotic on modulation of giardiasis. Dig Dis Sci 53, 2671–2679, 2008.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Kimberly D, Miller, and Jemal A: Cancer statistics. Cancer J Clin 66, 7–30, 2016.
   PubMed Web of Science ®Google Scholar
• Schnekenburger M and Diederich M: Epigenetics offer new horizons for colorectal cancer prevention. Curr Colorectal Cancer Rep 8, 66–81, 2012.
   PubMedGoogle Scholar
• Esther N, Nereida FF, Santiago V, and Jose LO: Factors determining colorectal cancer: The role of intestinal microbiota. Front Oncol 5, 220, 2015.
   PubMed Web of Science ®Google Scholar
• Subbaramaiah K and Dannenberg AJ: Cyclooxygenase 2: A molecular target for cancer prevention and treatment. Trends Pharmacol Sci, 24, 96–102, 2003.
   PubMed Web of Science ®Google Scholar
• Perše M and Cerar A: Morphological and molecular alteration in 1,2 dimethylhydrazine and azoxymethane induced colon carcinogenesis in rats. J Biomed Biotechnol, 2011, 473964, 2011.
   PubMedGoogle Scholar
• Lee SM and Lee WK: Inhibitory effects of lactic acid bacteria (LAB) on the azoxymethane-induced colonic preneoplastic lesions. J. Microbiol 38, 169–175, 2000.
   Web of Science ®Google Scholar
• Goldin BR: Intestinal microflora: Metabolism of drugs and carcinogens. Ann Med 22, 43–48, 1990.
   PubMed Web of Science ®Google Scholar
• Rowland IR and Gangoli SD: Role of gastrointestinal flora in the metabolic and toxicological activities of Xenobiotics. In: General and Applied Toxicology (2nd edn), Ballantyne B, Marrs TC, and Syverson T (eds.). London: Macmillan Publishers Ltd, 1999, pp. 561–576.
   Google Scholar
• Tjalsma H, Boleij A, Marchesi JR, and Dutilh BE: A bacterial driver-passenger model for colorectal cancer: Beyond the usual suspect. Nat Rev Microbiol 10, 575–582, 2012.
   PubMed Web of Science ®Google Scholar
• Dos Reis SA, do Conceicao LL, Siqueira PN, D. Rosa D, da silva LL, et al.: Review of the mechanisms of probiotic actions in the prevention of colorectal cancer. Nutr Res 37, 1–19, 2017.
   PubMed Web of Science ®Google Scholar
• Verma A and Shukla G: Modulation of apoptosis and immune response by synbiotic in experimental colorectal cancer. Int J Pharm Bio Sci 6, 529–543, 2015.
   Google Scholar